Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 51,986 | 143,782 | 127,419 | 109,300 | 108,735 |
| Cost of Goods | 14,666 | 30,690 | 27,132 | 23,826 | 25,447 |
| Gross Profit | 37,320 | 113,092 | 100,287 | 85,474 | 83,288 |
| Operating Expenses | 17,192 | 75,022 | 82,342 | 78,852 | 61,062 |
| Operating Income | 20,794 | 38,760 | 18,077 | 7,448 | 22,673 |
| Interest Expense | 18,151 | 18,309 | 18,250 | 18,443 | 18,457 |
| Other Income | 823 | 814 | 773 | 928 | 537 |
| Pre-tax Income | 3,466 | 21,265 | 600 | -10,067 | 4,753 |
| Income Tax | 9,446 | 5,069 | 1,196 | -2,540 | -2,448 |
| Net Income Continuous | -5,980 | 16,196 | -596 | -7,527 | 7,201 |
| Net Income | $-10,556 | $16,196 | $-596 | $-7,527 | $7,201 |
| EPS Basic Total Ops | -0.30 | 0.47 | -0.02 | -0.22 | 0.10 |
| EPS Basic Continuous Ops | -0.18 | 0.47 | -0.02 | -0.22 | 0.10 |
| EPS Diluted Total Ops | -0.26 | 0.43 | -0.02 | -0.22 | 0.34 |
| EPS Diluted Continuous Ops | -0.09 | 0.38 | -0.02 | -0.22 | 0.44 |
| EBITDA(a) | $54,916 | $69,731 | $42,841 | $30,206 | $43,993 |